Alzheimer's Diagnostic Guideline Validation: Exploration of Next Steps: Workshop Summary
Forum on Neuroscience and Nervous Systems Disorders, Board on Health Sciences Policy, Institute of Medicine
National Academies Press, Apr 5, 2012 - Medical - 15 pages
Scientific advances during the last decade now indicate that Alzheimer's disease is a continuous, progressive cognitive disease, most likely beginning many years before dementia is apparent. To discuss the next steps in validating new diagnostic guidelines for Alzheimer's disease, the IOM Forum on Neuroscience and Nervous System Disorders hosted a public workshop session at the Alzheimer's Association International Conference.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Academy of Engineering Academy of Sciences Alzheimer Center Alzheimer’s Association Alzheimer’s Disease Center amyloid ApoE4 asymptomatic atherosclerosis biomarker tests brain cardiac Cardiovascular Disease causative factor Center for Neurodegenerative cholesterol levels cholestyramine clinical trials cognitive decline cognitive impairment dementia Diagnostic Criteria Director DISEASE AND CHOLESTEROL Disease and Neurological drugs DZNE Forum on Neuroscience Framingham Heart Study function GABRIELLE SILVER GE Healthcare Group and NIA-AA Healthcare individuals Institute of Cardiovascular Institute of Medicine Institute of Neurological International Working Group LDL cholesterol lessons learned lipid hypothesis Mahley noted Medical and Scientific mg/dl Monique Breteler National Academy National Institute Neurology NIA-AA guidelines NIH Consensus Conference normal ofthe Parkinson’s Disease participants pathology patients Ph.D population potential prodromal Program published workshop summary reducing CHD risk factors ROBERT MAHLEY Rockefeller University role Scheltens School of Medicine Senior Investigator statins target Tau protein tion treatment University of California workshop rapporteurs workshop summary rests